Use of zoledronic acid in antiosteoporosis treatment is associated with a decreased blood lipid level in postmenopausal women with osteoporosis: A cohort study in China

Luo, W; Zhang, J; Xu, L; Zhou, Y; Xu, D; Lv, QJ; Xiao, Y; Yang, Q

Luo, W; Zhang, J (通讯作者),Peoples Hosp Leshan, Dept Endocrinol, Leshan City, Sichuan, Peoples R China.;Xu, L (通讯作者),Southwest Med Univ, Affiliated Hosp, Dept Endocrinol, Luzhou City, Sichuan, Peoples R China.

POSTGRADUATE MEDICINE, 2022; 134 (4): 406

Abstract

Objective This cohort study aimed to evaluate the protective effects of zoledronic acid (ZA) in lipidemia in postmenopausal women with osteoporosis. M......

Full Text Link